Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 10


Hybrid PET/optical imaging of integrin αVβ3 receptor expression using a (64)Cu-labeled streptavidin/biotin-based dimeric RGD peptide.

Kang CM, Koo HJ, An GI, Choe YS, Choi JY, Lee KH, Kim BT.

EJNMMI Res. 2015 Dec;5(1):60. doi: 10.1186/s13550-015-0140-0. Epub 2015 Oct 31.


VEGF₁₂₁-conjugated mesoporous silica nanoparticle: a tumor targeted drug delivery system.

Goel S, Chen F, Hong H, Valdovinos HF, Hernandez R, Shi S, Barnhart TE, Cai W.

ACS Appl Mater Interfaces. 2014 Dec 10;6(23):21677-85. doi: 10.1021/am506849p. Epub 2014 Nov 10.


Optical tecnology developments in biomedicine: history, current and future.

Nioka S, Chen Y.

Transl Med UniSa. 2011 Oct 17;1:51-150. Print 2011 Sep.


Non-invasive imaging for studying anti-angiogenic therapy effects.

Ehling J, Lammers T, Kiessling F.

Thromb Haemost. 2013 Mar;109(3):375-90. doi: 10.1160/TH12-10-0721. Epub 2013 Feb 14.


Positron emission tomography imaging of vascular endothelial growth factor receptor expression with (61)Cu-labeled lysine-tagged VEGF121.

Zhang Y, Hong H, Niu G, Valdovinos HF, Orbay H, Nayak TR, Chen X, Barnhart TE, Cai W.

Mol Pharm. 2012 Dec 3;9(12):3586-94. doi: 10.1021/mp3005269. Epub 2012 Nov 16.


Imaging key biomarkers of tumor angiogenesis.

Backer MV, Backer JM.

Theranostics. 2012;2(5):502-15. doi: 10.7150/thno.3623. Epub 2012 May 17.


Preclinical molecular imaging of tumor angiogenesis.

Zhu L, Niu G, Fang X, Chen X.

Q J Nucl Med Mol Imaging. 2010 Jun;54(3):291-308. Review.


A high-affinity human/mouse cross-reactive monoclonal antibody, specific for VEGFR-2 linear and conformational epitopes.

Huang J, Tan Y, Tang Q, Liu X, Guan X, Feng Z, Zhu J.

Cytotechnology. 2010 Jan;62(1):61-71. doi: 10.1007/s10616-010-9262-4. Epub 2010 Apr 13.


Protein-based tumor molecular imaging probes.

Lin X, Xie J, Chen X.

Amino Acids. 2011 Nov;41(5):1013-36. doi: 10.1007/s00726-010-0545-z. Epub 2010 Mar 17. Review.


Supplemental Content

Support Center